NewsEUROPEAN JOURNAL OF SURGICAL ONCOLOGY : THE JOURNAL OF THE EUROPEAN SOCIETY OF SURGICAL ONCOLOGY AND THE BRITISH ASSOCIATION OF SURGICAL ONCOLOGYSunday, March 29, 2026 · March 29, 2026
Ten-year of French multicentric experience in the management of peritoneal mesothelioma with 924 patients.
WHY IT MATTERS
Recent peer-reviewed research on Malignant peritoneal mesothelioma that may be relevant for patients and caregivers.
Diffuse malignant peritoneal mesothelioma (DMPM) is a rare disease for which only selected patients are eligible for cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of our study was to evaluate oncologic outcomes of different treatments patterns of DMPM at...
Related conditions
Related news
Int J Circumpolar Health · -249 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.…
Ther Adv Rare Dis · -219 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.…
Health Inf Sci Syst · -219 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.…
Mol Ther Nucleic Acids · -51 days ago
The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena
Published in Mol Ther Nucleic Acids. Giangrande PH et al.…